Howard Weintraub, MD

  • Specialties: Cardiology, Preventive Cardiology
  • Language: English
  • Phone: 212-263-0855

About Me

Conditions and Treatments

atherosclerosis, high cholesterol level, lipid disorders, lipid metabolism, high blood pressure disorder, prediabetes, metabolic syndrome, coronary heart disease, type 2 diabetes mellitus, chest pain, fainting, arteriosclerosis, obesity, heart throbbing, aortic valve disease, congestive heart failure (CHF), heart murmur, heart valve diseases, abnormal heart rhythms, mitral valve prolapse (MVP), rapid heartbeat, slow heartbeat, sarcoidosis, peripheral vascular disease (PVD), atrial septal defect (ASD), cardiac disease in pregnancy, heart muscle disease, heart tumor, ischemic cardiomyopathy, arterial occlusive disease, angina, heart attack, ventricular septal defect (VSD), claudication, atrial fibrillation, ventricular fibrillation, myocarditis, peripheral vascular disease (PVD), myocardial disease, rheumatic heart disease, ventricular tachycardia (V-tach), heart failure, endothelial dysfunction, inflammation of the heart valve, arteriosclerosis, an inflammation of the membrane surrounding the heart, dilated cardiomyopathy, vascular disease occlusive, carotid stenosis, cerebrovascular disorder, ventricular arrhythmia, mitral regurgitation (MR), heart disease, acute coronary syndrome, pulmonary hypertension, renal artery stenosis, mitral valve stenosis, carotid artery disease, renovascular, chronic venous insufficiency, aortic valve stenosis, mitral valve disease, atrioventricular septal defect, aortic valve insufficiency
Show More Conditions

Credentials

Positions

  • Clinical Professor, Department of Medicine

Board Certifications

    1985
  • American Board of Internal Medicine (Cardiovascular Disease)
    1979
  • American Board of Internal Medicine - Internal Medicine

Education and Training

  • 1982
  • Fellowship, NYU Medical Center, Cardiology
  • 1980
  • Fellowship, NYU Medical Center, Pulmonary Diseases
  • 1979
  • Residency, NYU Medical Center, Medicine
  • 1976
  • MD from New York University

Departments

Locations and Appointments

42 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Indemnity
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • Affinity
  • Affinity Exchange- Essential
  • Cigna EPO/POS
  • Cigna PPO
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield HMO
  • Empire Blue Cross Blue Shield Healthy NY
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Empire Blue Cross Blue Shield Pathways, Enhanced
  • HealthPlus Child Health (Amerigroup)
  • HealthPlus Family Health (Amerigroup)
  • HealthPlus Medicaid (Amerigroup)
  • HealthSmart (WTC)
  • Humana Medicare
  • Medicare
  • MetroPlus Child Health
  • MetroPlus Exchange Plans
  • MetroPlus Family Health
  • MetroPlus Medicaid
  • MultiPlan/PHCS PPO
  • Oxford Freedom
  • Oxford Liberty
  • Oxford Medicare
  • UnitedHealthcare Community & State Plan
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
  • WellCare Child Health
  • WellCare Family Health
  • WellCare Medicaid
  • WellCare Medicare
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.

NYULMC Center for the Prevention of Cardiovascular Disease
530 1st Avenue, HCC, Suite 4F
New York, NY 10016

Contact

Phone: 212-263-0855

Schedule Online

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

My Research

Our research is focused on the study of newer medications to lower Cholesterol and blood sugar; as well as reduction of cardiovascular risk in patients with existing cardiovascular disease.

We are involved in an exciting trial of a new class of medication to lower her LDL cholesterol. The patients who are being studied are those who had an acute coronary syndrome within the last year. this study we'll be looking at the effect of significant lowering of LDL cholesterol on cardiovascular events.

We are also involved in a study of omega-3 fatty acids in the reduction of cardiovascular events.

We are also investigating the cardiac effects of a new drug to treat type II diabetes.

The Center for Prevention of Cardiovascular Disease is also involved in a large trial that examines the effectiveness of different prevention modalities in patients with known coronary artery disease.

Publications

  • Prevalence of unrecognized diabetes, prediabetes and metabolic syndrome in patients undergoing elective percutaneous coronary intervention

    Balakrishnan, Revathi; Berger, Jeffrey S; Tully, Lisa; Vani, Anish; Shah, Binita; Burdowski, Joseph; Fisher, Edward; Schwartzbard, Arthur; Sedlis, Steven; Weintraub, Howard; Underberg, James A; Danoff, Ann; Slater, James A; Gianos, Eugenia 2015 Feb; 611-612, Diabetes/metabolism research & reviews — id: 1480312, year: 2015, page: 611, stat: JOURNAL ARTICLE
  • The role of testosterone therapy in cardiovascular mortality: culprit or innocent bystander?

    Tanna, Monique S; Schwartzbard, Arthur; Berger, Jeffery S; Alukal, Joseph; Weintraub, Howard 2015 Mar; 490-490, Current atherosclerosis reports — id: 1466712, year: 2015, page: 490, stat: Journal Article
  • Prognostic Value of Fasting vs. Non-Fasting Low Density Lipoprotein Cholesterol Levels on Long-term Mortality: Insight from the National Health and Nutrition Survey III (NHANES-III)

    Doran, Bethany; Guo, Yu; Xu, Jinfeng; Weintraub, Howard; Mora, Samia; Maron, David J; Bangalore, Sripal 2014 Aug; 546-553, Circulation — id: 1071142, year: 2014, page: 546, stat: JOURNAL ARTICLE
Read All Publications (40)